Abstract

Chronic Hepatitis C virus (HCV) infection still constitutes a major global health problem with almost half a million deaths per year. To date, the human hepatoma cell line Huh7 and its derivatives is the only cell line that robustly replicates HCV. However, even different subclones and passages of this single cell line exhibit tremendous differences in HCV replication efficiency. By comparative gene expression profiling using a multi-pronged correlation analysis across eight different Huh7 variants, we identified 34 candidate host factors possibly affecting HCV permissiveness. For seven of the candidates, we could show by knock-down studies their implication in HCV replication. Notably, for at least four of them, we furthermore found that overexpression boosted HCV replication in lowly permissive Huh7 cells, most prominently for the histone-binding transcriptional repressor THAP7 and the nuclear receptor NR0B2. For NR0B2, our results suggest a finely balanced expression optimum reached in highly permissive Huh7 cells, with even higher levels leading to a nearly complete breakdown of HCV replication, likely due to a dysregulation of bile acid and cholesterol metabolism. Our unbiased expression-profiling approach, hence, led to the identification of four host cellular genes that contribute to HCV permissiveness in Huh7 cells. These findings add to an improved understanding of the molecular underpinnings of the strict host cell tropism of HCV.

Highlights

  • Hepatitis C virus (HCV) chronically infects more than 70 million people worldwide and is the leading cause of liver cancer in most countries [1,2,3]

  • A basic characterization of different Huh7 passages including the relative capacity of their translation machinery has previously been published and found no obvious relation to HCV replication efficiency [27]

  • Even within the most robust cell culture model, the Huh7 cell line, HCV replicates to vastly varying levels in different variants of the Huh7 cell line

Read more

Summary

Introduction

Hepatitis C virus (HCV) chronically infects more than 70 million people worldwide and is the leading cause of liver cancer in most countries [1,2,3]. Even after successful treatment, patients remain at increased risk to developing hepatocellular carcinoma [5,6,7,8]. Due to the high number of undiagnosed infections and the lack of protection from re-infection, eradication of the disease without further basic research and the development of a prophylactic vaccine is unlikely [9]. HCV belongs to the Hepacivirus genus in the Flaviviridae family and comprises eight genotypes with at least 86 subtypes [10,11]. The virus particle is enveloped and has a single-stranded positive-sense

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call